Urinary incontinence — supplement protocol and what actually works
Urinary incontinence affects roughly 25–45% of adult women and 11–34% of older men. The single highest-yield intervention is pelvic floor muscle training (PFMT) supervised by a qualified physiotherapist — outperforming most pharmaceuticals and certainly all supplements. Supplements have a narrow but real adjunct role, mostly in overactive bladder (pumpkin seed extract, magnesium) and as background support (vitamin D in deficiency). This page covers where evidence is genuine and where the marketing far outruns it.
Where the supplement evidence sits
Pumpkin seed extract (Cucurbita pepo)
500–1000 mg/day standardised extract; 12 weeks
Several small trials and meta-analyses (Sasaki 2014, Nishimura 2014) show modest reductions in urinary urgency, frequency, and nocturia with standardised pumpkin seed extract in mixed populations including older adults with overactive bladder. Effect sizes are modest. Reasonable trial in non-severe OAB before or alongside pharmacotherapy.
Magnesium glycinate
200–400 mg elemental magnesium daily
Magnesium acts on smooth muscle (including detrusor) and a small Israeli trial (Gordon 1998) suggested modest improvement in OAB symptoms with magnesium hydroxide. Most adults have marginal dietary magnesium, making repletion a reasonable backstop. Effect is modest.
Vitamin D3 (if deficient)
1000–2000 IU/day vitamin D3 to a 25-OH-D target of 30–50 ng/mL
Vitamin D deficiency is associated with overactive bladder and urge incontinence in observational data, possibly via effects on pelvic floor and detrusor smooth muscle. Causation is uncertain, but repletion is low-harm and reasonable in deficient patients.
D-Mannose and cranberry extract — for UTI-related urge symptoms
D-mannose 2 g/day; cranberry standardised to 36 mg PAC/day
If urinary urgency is driven by frequent UTIs, addressing the UTI risk reduces urge symptoms. D-mannose and cranberry have modest preventive evidence in recurrent UTI; both are reasonable adjuncts when UTI history is part of the picture.
Saw palmetto — for male LUTS, modest if at all
320 mg/day standardised extract; 12+ weeks
Large trials (STEP, CAMUS) of saw palmetto in BPH-related LUTS have been largely null. Effect on urge incontinence is even less clear. Reasonable low-harm trial in mild male LUTS; do not expect dramatic effect.
What actually works — beyond supplements
- Pelvic floor muscle training (PFMT) with a qualified physiotherapist — the highest-yield intervention for stress incontinence and a major adjunct for urge incontinence. Supervised programs outperform self-directed Kegels. ~70% improvement in stress incontinence severity with 12-week PFMT.
- Bladder training — scheduled voiding with progressively extended intervals; useful for urge incontinence and overactive bladder.
- Lifestyle modification — weight loss in overweight patients (each 5–10% body weight loss reduces incontinence episodes); caffeine reduction (caffeine is a bladder irritant); alcohol reduction; constipation treatment (chronic constipation worsens incontinence).
- Fluid management — not less fluid (which worsens UTI risk and produces concentrated, irritating urine), but spaced through the day with less in the 2–3 hours before bed.
- Pharmacological treatment — anticholinergics (oxybutynin, tolterodine, trospium) or beta-3 agonists (mirabegron, vibegron) for urge incontinence; topical estrogen for postmenopausal women with genitourinary syndrome; duloxetine in some jurisdictions for stress incontinence.
- Procedural interventions — midurethral sling, periurethral bulking, sacral neuromodulation, intravesical botulinum toxin — for refractory disease.
- Treating contributing medications — diuretics timed to avoid nocturia; review of alpha-blockers, sedatives, calcium channel blockers, ACE-inhibitors, gabapentinoids for incontinence contribution.
What to skip
- "Bladder support" combination products at sub-therapeutic doses — typically multi-ingredient blends without trial-cited doses of any single component.
- Hyaluronic acid oral supplements for bladder lining — intravesical hyaluronic acid has some evidence in interstitial cystitis; oral hyaluronic acid does not reach the bladder lining.
- "Detox" and "cleanse" products marketed for bladder health — bladder doesn't need cleansing; if anything, dehydration worsens symptoms.
- Restricting fluid intake to manage urgency — produces concentrated, irritating urine that worsens symptoms; UTI risk increases.
- Chronic OTC sleep aids with anticholinergic effects (diphenhydramine) — worsen urinary retention and overflow incontinence, particularly in older adults.
- Hormone "biohacking" for postmenopausal incontinence — topical vaginal estrogen has strong evidence and is the right intervention; high-dose systemic regimens are not.
What to track
Use a bladder diary for 3–7 days: voiding times, leakage episodes, intake. Validated severity tools include the ICIQ-UI SF (short-form, 4 questions, easy to track over time). Track during a 12-week intervention. PFMT effect should be evident by 8–12 weeks of consistent program.